Skip to main content
Top
Published in: Inflammation 1/2011

01-02-2011

Immune Dysregulation in Patients with Severe Acute Pancreatitis

Authors: YinFeng Shen, NaiQiang Cui, Bing Miao, ErPeng Zhao

Published in: Inflammation | Issue 1/2011

Login to get access

Abstract

To investigate patients with severe acute pancreatitis (SAP) by dynamic levels of pro-/anti-inflammatory cytokines and endotoxin (ET) in plasma and the relationship between immunity and infection, organ dysfunction. Seventy-two patients with SAP were recruited. The ET, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-4 (IL-4) were determined on admission and days 3, 7, and 14. For comparison, patients were analyzed through infection group versus non-infection group, multiple organ dysfunction syndrome (MODS) group versus non-MODS group. There were sixteen patients with secondary infection, twenty-two with MODS, and nine deaths. The infection group had higher levels of ET than the non-infection group on days 3 and 7. The dynamic cytokine levels of patients in the MODS group were unanimous with those outcomes in the infection group. The levels of cytokines in the infection group were different from the non-infection group, with more levels of TNF-α, IL-6 on days 3 and 7 and less on days 14, and more levels of IL-10, IL-4 on days7 and 14. The levels of TNF-α, IL-6 in the MODS group were different from the non-MODS group, with more levels on days 3 and 7, and less levels on days 14. Immune dysregulation may play an important role in infection and organ dysfunction for patients with SAP.
Literature
1.
go back to reference Bumbasirevic, V., D. Radenkovic, Z. Jankovic, et al. 2009. Severe acute pancreatitis: overall and early versus late mortality in intensive care units. Pancreas 38: 122–125.CrossRefPubMed Bumbasirevic, V., D. Radenkovic, Z. Jankovic, et al. 2009. Severe acute pancreatitis: overall and early versus late mortality in intensive care units. Pancreas 38: 122–125.CrossRefPubMed
2.
go back to reference Braganza, J.M. 2001. Towards a novel treatment strategy for acute pancreatitis. 1. Reappraisal of the evidence on aetiogenesis. Digestion 63: 69–91.CrossRefPubMed Braganza, J.M. 2001. Towards a novel treatment strategy for acute pancreatitis. 1. Reappraisal of the evidence on aetiogenesis. Digestion 63: 69–91.CrossRefPubMed
3.
go back to reference Mizuguchi, T., M. Mukaiya, H. Imaizumi, et al. 2004. Successful management of severe acute pancreatitis with multiple organ failure. Pancreas 28: 211–213.CrossRefPubMed Mizuguchi, T., M. Mukaiya, H. Imaizumi, et al. 2004. Successful management of severe acute pancreatitis with multiple organ failure. Pancreas 28: 211–213.CrossRefPubMed
4.
go back to reference Beger, H.G., B. Rau, and R. Isenmann. 2003. Natural history of necrotizing pancreatitis. Pancreatology 3: 93–101.CrossRefPubMed Beger, H.G., B. Rau, and R. Isenmann. 2003. Natural history of necrotizing pancreatitis. Pancreatology 3: 93–101.CrossRefPubMed
5.
go back to reference Büchler, M.W., B. Gloor, C.A. Müller, et al. 2000. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Annals of Surgery 232: 619–626.CrossRefPubMed Büchler, M.W., B. Gloor, C.A. Müller, et al. 2000. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Annals of Surgery 232: 619–626.CrossRefPubMed
6.
go back to reference Tsui, N.C., E. Zhao, Z. Li, et al. 2009. Microbiological findings in secondary infection of severe acute pancreatitis: a retrospective clinical study. Pancreas 38: 499–502.CrossRefPubMed Tsui, N.C., E. Zhao, Z. Li, et al. 2009. Microbiological findings in secondary infection of severe acute pancreatitis: a retrospective clinical study. Pancreas 38: 499–502.CrossRefPubMed
7.
go back to reference Heinrich, S., M. Schäfer, V. Rousson, et al. 2006. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Annals of Surgery 243: 154–168.CrossRefPubMed Heinrich, S., M. Schäfer, V. Rousson, et al. 2006. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Annals of Surgery 243: 154–168.CrossRefPubMed
8.
go back to reference Balog, A., Z. Gyulai, L.G. Boros, et al. 2005. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 30: e46–e50.CrossRefPubMed Balog, A., Z. Gyulai, L.G. Boros, et al. 2005. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 30: e46–e50.CrossRefPubMed
9.
go back to reference Zhang, X.P., H.Q. Chen, F. Liu, et al. 2009. Advances in researches on the immune dysregulation and therapy of severe acute pancreatitis. Journal of Zhejiang University. Science. B 10: 493–498.CrossRefPubMed Zhang, X.P., H.Q. Chen, F. Liu, et al. 2009. Advances in researches on the immune dysregulation and therapy of severe acute pancreatitis. Journal of Zhejiang University. Science. B 10: 493–498.CrossRefPubMed
10.
go back to reference Bradley 3rd, E.L. 1993. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Archives of Surgery 128: 586–590.PubMed Bradley 3rd, E.L. 1993. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Archives of Surgery 128: 586–590.PubMed
11.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992;20: 864–874. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992;20: 864–874.
12.
go back to reference Xia, S.H., C.X. Hu, J.M. Fang, et al. 2008. G[alpha] i2 and G[alpha] q expression change in pancreatic tissues and BN52021 effects in rats with severe acute pancreatitis. Pancreas 37: 170–175.CrossRefPubMed Xia, S.H., C.X. Hu, J.M. Fang, et al. 2008. G[alpha] i2 and G[alpha] q expression change in pancreatic tissues and BN52021 effects in rats with severe acute pancreatitis. Pancreas 37: 170–175.CrossRefPubMed
13.
go back to reference Makhija, R., and A.N. Kingsnorth. 2002. Cytokine storm in acute pancreatitis. Journal of Hepato-biliary-pancreatic Surgery 9: 401–410.CrossRefPubMed Makhija, R., and A.N. Kingsnorth. 2002. Cytokine storm in acute pancreatitis. Journal of Hepato-biliary-pancreatic Surgery 9: 401–410.CrossRefPubMed
14.
go back to reference Zhang, X., L. Chen, L. Luo, et al. 2008. Study of the protective effects of dexamethasone on ileum mucosa injury in rats with severe acute pancreatitis. Pancreas 37: e74–e82.CrossRefPubMed Zhang, X., L. Chen, L. Luo, et al. 2008. Study of the protective effects of dexamethasone on ileum mucosa injury in rats with severe acute pancreatitis. Pancreas 37: e74–e82.CrossRefPubMed
15.
go back to reference Holmes, C.L., J.A. Russell, and K.R. Walley. 2003. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124: 1103–1115.CrossRefPubMed Holmes, C.L., J.A. Russell, and K.R. Walley. 2003. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124: 1103–1115.CrossRefPubMed
16.
go back to reference Rahman, S.H., G. Salter, J.H. Holmfield, et al. 2004. Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260 T CD14 genotype are associated with severe acute pancreatitis. Critical Care Medicine 32: 2457–2463.CrossRefPubMed Rahman, S.H., G. Salter, J.H. Holmfield, et al. 2004. Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260 T CD14 genotype are associated with severe acute pancreatitis. Critical Care Medicine 32: 2457–2463.CrossRefPubMed
17.
go back to reference de Madaria, E., J. Martínez, L. Sempere, et al. 2008. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood. Pancreas 37: 295–301.CrossRef de Madaria, E., J. Martínez, L. Sempere, et al. 2008. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood. Pancreas 37: 295–301.CrossRef
18.
go back to reference Beger, H.G., and B.M. Rau. 2007. Severe acute pancreatitis: clinical course and management. World Journal of Gastroenterology 13: 5043–5051.PubMed Beger, H.G., and B.M. Rau. 2007. Severe acute pancreatitis: clinical course and management. World Journal of Gastroenterology 13: 5043–5051.PubMed
19.
go back to reference Ammori, B.J., P. Fitzgerald, P. Hawkey, et al. 2003. The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas 26: 18–22.CrossRefPubMed Ammori, B.J., P. Fitzgerald, P. Hawkey, et al. 2003. The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas 26: 18–22.CrossRefPubMed
20.
go back to reference Liu, H., W. Li, X. Wang, et al. 2008. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas 36: 192–196.CrossRefPubMed Liu, H., W. Li, X. Wang, et al. 2008. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas 36: 192–196.CrossRefPubMed
21.
go back to reference Büchler, M.W., B. Gloor, C.A. Müller, et al. 2000. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Annals of Surgery 232: 619–626.CrossRefPubMed Büchler, M.W., B. Gloor, C.A. Müller, et al. 2000. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Annals of Surgery 232: 619–626.CrossRefPubMed
22.
go back to reference Tellado, J.M. 2007. Prevention of infection following severe acute pancreatitis. Current Opinion in Critical Care 13: 416–420.CrossRefPubMed Tellado, J.M. 2007. Prevention of infection following severe acute pancreatitis. Current Opinion in Critical Care 13: 416–420.CrossRefPubMed
23.
go back to reference Osman, M.O., B. Gesser, J.T. Mortensen, et al. 2002. Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis. Cytokine 17: 53–59.CrossRefPubMed Osman, M.O., B. Gesser, J.T. Mortensen, et al. 2002. Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis. Cytokine 17: 53–59.CrossRefPubMed
24.
go back to reference Matsuda, N., J. Nishihira, Y. Takahashi, et al. 2006. Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia. American Journal of Respiratory Cell and Molecular Biology 35: 198–205.CrossRefPubMed Matsuda, N., J. Nishihira, Y. Takahashi, et al. 2006. Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia. American Journal of Respiratory Cell and Molecular Biology 35: 198–205.CrossRefPubMed
25.
go back to reference Liu, H.B., N.Q. Cui, Q. Wang, et al. 2008. Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis. Pancreas 36: e10–e15.CrossRefPubMed Liu, H.B., N.Q. Cui, Q. Wang, et al. 2008. Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis. Pancreas 36: e10–e15.CrossRefPubMed
26.
go back to reference Ohmoto, K., and S. Yamamoto. 2005. Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: clinical implications. Hepato-Gastroenterology 52: 990–994.PubMed Ohmoto, K., and S. Yamamoto. 2005. Serum interleukin-6 and interleukin-10 in patients with acute pancreatitis: clinical implications. Hepato-Gastroenterology 52: 990–994.PubMed
27.
go back to reference Ueda, T., Y. Takeyama, T. Yasuda, et al. 2006. Immunosuppression in patients with severe acute pancreatitis. Journal of Gastroenterology 41: 779–784.CrossRefPubMed Ueda, T., Y. Takeyama, T. Yasuda, et al. 2006. Immunosuppression in patients with severe acute pancreatitis. Journal of Gastroenterology 41: 779–784.CrossRefPubMed
28.
go back to reference Rau, B.M., C.M. Krüger, C. Hasel, et al. 2006. Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis. Pancreas 33: 174–183.CrossRefPubMed Rau, B.M., C.M. Krüger, C. Hasel, et al. 2006. Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis. Pancreas 33: 174–183.CrossRefPubMed
29.
go back to reference Shi, C.B., X. Zhao, A. Lagergren, et al. 2006. Immune status and inflammatory response differ locally and systemically in severe acute pancreatitis. Scandinavian Journal of Gastroenterology 41: 472–480.CrossRefPubMed Shi, C.B., X. Zhao, A. Lagergren, et al. 2006. Immune status and inflammatory response differ locally and systemically in severe acute pancreatitis. Scandinavian Journal of Gastroenterology 41: 472–480.CrossRefPubMed
30.
go back to reference Bone, R. 1996. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and what we do not know about cytokine regulation. Critical Care Medicine 24: 163–172.CrossRefPubMed Bone, R. 1996. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and what we do not know about cytokine regulation. Critical Care Medicine 24: 163–172.CrossRefPubMed
Metadata
Title
Immune Dysregulation in Patients with Severe Acute Pancreatitis
Authors
YinFeng Shen
NaiQiang Cui
Bing Miao
ErPeng Zhao
Publication date
01-02-2011
Publisher
Springer US
Published in
Inflammation / Issue 1/2011
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9205-4

Other articles of this Issue 1/2011

Inflammation 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.